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Summary
 
The function of the minor subset of T lymphocytes bearing the 
 
gd
 
 T cell antigen receptor is
uncertain. Although some 
 
gd
 
 T cells react to microbial products, responsiveness has only rarely
been demonstrated toward a bacterial antigen from a naturally occurring human infection. Sy-
novial fluid lymphocytes from patients with Lyme arthritis contain a large proportion of 
 
gd
 
cells that proliferate in response to the causative spirochete, 
 
Borrelia burgdorferi.
 
 Furthermore,
synovial 
 
gd
 
 T cell clones express elevated and sustained levels of the ligand for Fas (APO-1,
CD95) compared to 
 
ab
 
 T cells, and induce apoptosis of Fas
 
high
 
 CD4
 
1
 
 synovial lymphocytes.
The findings suggest that 
 
gd
 
 T cells contribute to defense in human infections, as well as man-
ifest an immunoregulatory function at inflammatory sites by a Fas-dependent process.
W
 
hile most T lymphocytes express a TCR composed
of 
 
a
 
 and 
 
b
 
 chains, a subpopulation of T cells bear-
ing alternate 
 
g
 
 and 
 
d
 
 chains exists as a minor subset of pe-
ripheral blood lymphocytes (PBL)
 
1
 
 (1). While the function
of 
 
gd
 
 T cells is uncertain, a clue may lie in their increased
proportion at epithelial barriers, during certain infections,
and at sites of chronic inflammation such as synovial tissue
in rheumatoid arthritis (2–7). Some 
 
gd
 
 T cells respond to
bacterial products and can be identified after infection of
mice with particular bacteria (8–15). However, in humans,
leprosy is the only infectious disease to date in which 
 
gd
 
cells from affected individuals have been shown to respond
to the causative organism (9).
 
gd
 
 T cells frequently manifest cytolytic activity toward
a broad array of target cells (2, 16). Such a spectrum of cy-
tolysis might occur when a target molecule is widely ex-
pressed, such as the Fas antigen (APO-1, CD95) (17). Fas
is a 45-kD cell surface molecule that mediates apoptosis
and is a member of a family of molecules that includes the
type I receptor for TNF. Fas is one of the principle compo-
nents responsible for T cell–mediated cytotoxicity (18–20).
Expression of mRNA for the Fas ligand (Fas
 
L
 
) was origi-
nally described as being transiently expressed by activated
 
ab
 
 T cells, although higher mRNA levels were noted in
 
gd
 
 T cells (21). More recent findings have noted constitu-
tive expression of Fas
 
L
 
 by nonlymphoid cells, including
Sertoli cells of the testis (22) and certain components of the
eye (23). Fas
 
L
 
 expression by these tissues parallels their ability
to suppress immune-mediated inflammation. These collec-
tive observations suggested that 
 
gd
 
 T cells in Lyme arthritis
might respond to 
 
Borrelia burgdorferi
 
 as well as contribute to
regulation of the synovial inflammatory infiltrate.
 
Materials and Methods
 
Patients.
 
Lyme arthritis patients came from areas endemic for
Lyme disease and were followed at the Lyme Disease Clinic at
the University of Medicine and Dentistry of New Jersey, Robert
Wood Johnson Medical School. All patients had histories, exams,
and serologies consistent with Lyme arthritis, including 
 
Borrelia
 
-
specific antibody titers that were higher in synovial fluid relative
to serum. Synovial fluid lymphocytes were examined from seven
patients with Lyme arthritis of 6-mo to 3.2-yr duration.
 
Flow Cytometry.
 
Lymphocytes were isolated from peripheral
blood or synovial fluid by Ficoll–Hypaque centrifugation. Cells
were stained with the indicated fluorochrome-conjugated anti-
body at 4
 
8
 
C for 30 min. Antibodies were specific for TCR-
 
ab
 
(JOVI-1; Ancell Corp., Bayport, MN), TCR-
 
gd
 
 (5A6.E9; T Cell
Sciences, Inc., Cambridge, MA), TCR-V
 
d
 
1 and TCR-V
 
d
 
2 (AB
and BB3, respectively, courtesy of Dr. Alessandro Moretta, Uni-
 
1
 
Abbreviation used in this paper:
 
 PBL, peripheral blood lymphocytes.
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versity of Genoa, Genoa, Italy), CD4 (SFCI12T4D11; Coulter
Corp., Hialeah, FL), CD8 (SFCI21Thy2D3; Coulter Corp.), Fas
(M38) (24) and Fas
 
L
 
 (polyclonal C-20; Santa Cruz Biotechnol-
ogy, Santa Cruz, CA; or monoclonal A11 [25]). Surface staining
for Fas
 
L
 
 was performed by one of three methods. The first ap-
proach used a fusion protein composed of the extracellular do-
main of murine Fas linked to the human Ig Fc portion (Fas-Fc)
(26). This was followed by goat anti–human Fc–biotin and then
avidin–phycoerythrin. Control staining was accomplished by
staining for surface IL4 using an IL4 receptor–Fc fusion protein.
Alternatively, surface Fas
 
L
 
 was measured using either a rabbit anti-
serum to the extracellular carboxyl-terminal portion of human
Fas
 
L
 
 and purified on a Fas
 
L
 
 sepharose column (C-20), or mono-
clonal antibody A11 that recognizes both mouse and human Fas
(25). To measure Fas
 
L
 
 induction, cells were examined 3 h after
stimulation with PMA (10 ng/ml) and ionomycin (250 ng/ml),
in the absence or presence of metalloprotease inhibition using 5
mM EDTA (27). Samples were analyzed on a Coulter Elite flow
cytometer (Coulter Corp.) and at least 2 
 
3
 
 10
 
4
 
 events were accu-
mulated for analysis.
 
Proliferation Assays and Derivation of Lyme Synovial 
 
gd
 
 T Cell
Clones.
 
Synovial fluid lymphocytes were cultured in AIM-V se-
rum-free medium (GIBCO BRL, Gaithersburg, MD) in either
bulk cultures (10
 
6
 
/ml) for phenotyping, or in round-bottomed
microtiter wells (10
 
5
 
/well) for proliferation assays. Cells were
stimulated with 3 
 
m
 
g/ml of a sonicate of 
 
B. burgdorferi
 
 grown in
BSK II medium as previously described (28). Triplicate cultures
were pulsed with 
 
3
 
H-TdR during the last 18 h of a 6-d culture,
harvested, and counted. From parallel cultures, responding cells
were cloned at 0.3 cells/well in AIM-V with 5% FCS in the pres-
ence of irradiated PBL (3 
 
3
 
 10
 
5
 
/well), human recombinant IL2
(10 U/ml), and 3 
 
m
 
g/ml of 
 
B. burgdorferi
 
 sonicate. Responding
wells were phenotyped and the 
 
gd
 
 cells expanded by restimula-
tion at 10-d intervals.
 
PCR Analysis of Synovial Fluid T Lymphocyte V
 
d
 
 Repertoire.
 
Semi-quantitative PCR was performed on samples using cDNA
prepared from oligo-dT–primed RNA and reverse transcriptase
(GIBCO BRL) as previously described (29). The 5
 
9
 
 V
 
d
 
- and
C
 
d
 
-specific primers are modifications of published sequences (30)
as follows: V
 
d
 
1: 5
 
9
 
-AGCAACTTCCCAGCAAAGAG-3
 
9
 
; V
 
d
 
2:
5
 
9
 
-AGGAAGACCCAAGGTAACACAA-3
 
9
 
; V
 
d
 
3: 5
 
9
 
-CACT-
GTATATTCAAATCCAGA-3
 
9
 
; V
 
d
 
4: 5
 
9
 
-TGACACCAGTG-
ATCCAAGTTA-3
 
9
 
; V
 
d
 
5: 5
 
9
 
-CTGTGACTATACTAACAG-
CATGT-3
 
9
 
; V
 
d
 
6: 5
 
9
 
-TATCATGGATTCCCAGCC-3
 
9
 
; 5
 
9
 
C
 
d
 
:
5
 
9
 
-CTTGTCTGGTGCAG-3
 
9
 
; 3
 
9
 
C
 
d
 
: 5
 
9
 
-CTTCACCAGACAA-
GCGACAT-3
 
9
 
. A PCR reaction master mix that was common
to all samples contained 100 mM Tris HCl, pH 8.3, 500 mM
KCl, 2 mM MgCl
 
2
 
, 200 
 
m
 
M dNTPs, with 25 pmoles of 3
 
9 Cd
primer, 2.2 mCi a-32P-dCTP, and 2.5 U Taq polymerase
(GIBCO BRL) per tube. The final volume was 100 ml and
contained 10 ng cDNA, and 25 pmoles of individual Vd primer.
Samples were run on a thermocycler (model 9600; Perkin-Elmer
Corp., Norwalk, CT) for 24 cycles using the parameters: cycle 1:
948C 3 3 min, 508C 3 45 s, 728C 3 1 min; cycles 2–23: 948C 3
30 s, 508C 3 45 s, 728C 3 1 min; cycle 24: 948C 3 30 s, 508C 3
45 s, 728C 3 7 min. Samples were resolved on a 29 cm 10%
polyacrylamide gel containing 7 M urea in TBE buffer and elec-
trophoresed at 80 V for 18 h. The gel was dried and developed
on an analyzer (Betascope 603; Betagen, Waltham, MA). The
percentage expression of each Vd was assigned by dividing the
actual cpm for a specific Vd by the total cpm for Vd1–Vd6 after
correction for the total Cd message in each sample.
Assay of Cytotolytic Activity. Faslow variants of the wild-type
Jurkat T cell line, H7 (3% normal surface Fas levels) and B4 (1%
normal Fas levels), were derived through irradiation mutagenesis
using five doses of 200 Rads each, delivered at 5-d intervals. After
each irradiation, cells were cultured in wells coated with lytic
anti-Fas antibody (M2, 3 mg/ml)(24). The Faslow variants and
wild-type Jurkat cells were incubated with 51Chromium (51Cr)
for 1 h, washed, and then mixed at various effector/target ratios
with cloned Vd1 cells in a total volume of 200 ml. After a 4-h in-
cubation at 378C, 100 ml of supernatant were removed and
counted for g emission. Spontaneous release was determined
from labeled targets in the absence of effector cells. Maximum re-
lease was determined by lysing target cells with 1.0 N HCl. The
percentage of specific 51Cr release was calculated as:
.
Blocking studies of cytolysis were performed using either specific
antibodies at the concentrations indicated, or Fas-Fc fusion pro-
tein (10 mg/ml) preincubated with appropriate cells for 30 min
before beginning the cytolysis assay. Antibodies used were spe-
cific for TCR-gd (5A6.E9), HLA class I (W6/32; Accurate
Chemical and Science Corp., Westbury, NY), HLA class II (L243;
Becton Dickinson & Co., Immunocytometer, Sys., Mountain-
view, CA), LFA-1 (R7.1; Biosource International, Camarillo,
CA), or Fas (M38).
TUNEL Assay for Apoptosis. Cells were initially stained for
expression of surface gd, CD4, or CD8 and then fixed for 15 min
in 1% paraformaldehyde. Cell membranes were then permeabi-
lized for 15 min using 70% ethanol at 48C. Samples were incu-
bated at 378C for 1 h in 100 ml containing 10 U terminal
deoxyribosyltransferase and 0.5 nM dUTP-biotin (Boehringer
Mannheim Biochemicals Corp., Indianapolis, IN) (31, 32). Spec-
imens were washed twice with PBS/1% BSA and incubated with
a 1:50 dilution of avidin-tricolor (Caltag Labs., South San Fran-
cisco, CA) at 48C for 30 min. Cells were washed twice and ana-
lyzed by flow cytometry.
Results
Reciprocal Changes in Synovial Fluid CD41 and gd T Cells
with Borrelia Stimulation. Synovial fluid lymphocytes were
examined from seven patients with Lyme arthritis of 6 mo
to 3.2-y duration. These contained a predominance of CD41
over CD81 ab T cells in only four of seven cases (Fig. 1 A,
Table 1), compared to a consistent CD4 predominance in
PBL. Also present in the synovial mononuclear cells was a
remarkable percentage of gd T cells (18.9 6 6.8%) (Fig. 1 A,
Table 1), compared to z1–5% in PBL (Reference 1 and
see Fig. 3). The synovial gd population was largely devoid of
surface CD4, and only a minor proportion (z20% on aver-
age) expressed low to intermediate levels of CD8 (Fig. 1 B).
In addition, whereas gd T cells from PBL express predom-
inantly the Vd2 gene product (33), Lyme arthritis synovial
fluid gd cells were primarily of the Vd1 subset, with lesser
proportions of Vd2 and Vd3 cells. This was determined by
both flow cytometry using Vd-specific antibodies (Fig. 1 A),
and semi-quantitative PCR using specific Vd primers (Fig. 2).
Stimulation of Lyme arthritis synovial fluid mononuclear
cells with a sonicate of B. burgdorferi (strain N40) induced
vigorous proliferation (Table 1), yielding a two- to three-
% Specific Cr  release 51  =
experimental cpm spontaneous cpm–
maximal cpm spontaneous cpm–
--------------------------------------------------------------------------
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fold increase in cell number over 6 d. During this period,
the composition of T cell subsets shifted considerably. Al-
though the percentage of CD81 cells changed only slightly,
there was frequently a striking loss in the proportion of
CD41 cells by as much as threefold. Thus, despite the in-
crease in total lymphocyte number during the 6-d culture,
there was frequently little change or even a decrease in the
absolute number of CD41 cells, as illustrated by patient no. 2
in Table 2. This was paralleled by a reciprocal increase in
gd T cells, in some cases to as much as 50% of the cultured
synovial lymphocytes (Fig. 1, Table 1). These continued to
be mostly Vd1 cells as determined by both antibody (Fig. 1 A)
and PCR (Fig. 2) analysis.
The loss of CD41 synovial cells might have resulted
from unresponsiveness of this subset to B. burgdorferi, and
hence overgrowth by the CD81 and gd1 subsets. How-
ever, this seems unlikely since we have previously observed
that PBL also proliferate strongly to B. burgdorferi with an
expansion of predominantly CD41 cells (28). Alternatively,
because PBL contain only a small proportion of gd cells
(1), the gd subset might be responsible for the loss of CD41
cells in Borrelia-activated synovial cultures. Consistent with
this notion was the one case (patient no. 6) where the per-
Figure 1. Reciprocal shifts in the percentages of gd versus CD41 T
cells after stimulation by B. burgdorferi of Lyme arthritis synovial fluid T cells.
Synovial fluid mononuclear cells, isolated by Ficoll-Hypaque centrifugation,
were analyzed either freshly isolated or 6 d after stimulation with a 3 mg/ml
sonicate of B. burgdorferi. (A) Flow cytometric analysis of synovial fluid
mononuclear cells reveals a prominent population of gd cells that ex-
presses mostly Vd1 and expands dramatically following stimulation with
B. burgdorferi. The numbers in the histograms indicate the percent of pos-
itively stained cells. (B) Synovial fluid gd cells are predominantly CD42
CD82. FACSÒ  staining demonstrates that gd cells are largely devoid of
CD4 and only a minor subset expresses low to intermediate levels of sur-
face CD8.
Table 1. Phenotypic Changes in Lyme Arthritis Synovial Fluid T Cells following Borrelia Stimulation
Patient
No.
Before Borrelia stimulation After Borrelia stimulation Proliferation
%CD4/%CD8 %TCR-gd %CD4/%CD8 %TCR-gd Medium 1 Borrelia
cpm
1 29.7/45.3 23.8 9.0/39.8 56.8 5,316 178,964
2 52.6/28.2 20.0 18.0/29.6 45.8 526 19,122
3 27.8/45.7 15.7 29.0/33.2 29.9 17,369 82,440
4 64.4/16.6 11.1 55.1/8.8 11.8 2,791 32,418
5 25.4/39.5 13.5 7.4/38.3 41.5 4,516 51,278
6 36.5/18.8 30.8 51.4/28.9 2.9 2,937 44,474
7 45.4/35.3 11.6 14.0/23.6 25.7 30,230 89,533
Synovial fluid lymphocytes were isolated by Ficoll-Hypaque. Specimens were analyzed freshly isolated, or placed in serum-free AIM-V medium
(GIBCO BRL) with a sonicate of B. burgdorferi (3 mg/ml) and re-phenotyped after 7 d. Proliferation of 5 3 104 cells/well was measured by 3H-TdR
uptake during the last 18 h of culture. cpm, mean of triplicate cultures. Standard deviations were ,15%.
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centage of gd T cells did not increase following stimulation
with B. burgdorferi. In this instance, the proportion of CD41
cells actually increased from 36.5 to 51.4% (Table 1).
Synovial CD41 Cells are Fashigh Whereas Synovial gd T Cell
Clones are FasLhigh. To more directly address the possibility
that synovial gd cells might be cytolytic toward the CD41
subset, gd T cell clones were derived from synovial fluids
of two Lyme arthritis patients using a sonicate of B. burgdorf-
eri and irradiated autologous PBL. A panel of 18 Borrelia-
responsive gd clones was established, the majority of which
express Vd1 and lack surface CD4 and CD8. DNA se-
quencing of the d chain from seven clones confirmed that
they all express Vd1, but were otherwise each unique and
contained varying degrees of N region diversity (Roessner,
K., manuscript in preparation).
gd T cells frequently manifest cytolytic activity toward a
broad array of target cells (2, 16). Such a spectrum of cytol-
ysis might occur when a target molecule is widely ex-
pressed, as is the case with the apoptosis-inducing mole-
cule, Fas (17). As shown in Fig. 3, Fas expression by fresh
CD41 PBL was low to negligible, but was present on a
large proportion of CD41 synovial lymphocytes. By con-
trast, the CD81 and gd1 subsets of PBL or synovial lym-
phocytes displayed considerably lower levels of Fas.
Surface expression of FasL protein by B. burgdorferi–reac-
tive gd and CD41 ab T cell clones was examined by flow
cytometry using two methods, a Fas-Fc fusion protein as
well as a purified anti–human FasL rabbit antiserum. Con-
Figure 2. Semi-quantitative PCR using 59 primers specific for Vd1-
Vd6 or Cd, and a 39 primer specific for Cd. (A) Actual polyacrylamide
gel, imaged on a Betascope, of the Vd bands for Lyme synovial fluid
mononuclear cells either freshly isolated (lane 1) or six days after culture
with B. burgdorferi (lane 2). No Vd product was detected from PBL (lane 3)
using the parameters of this assay. At the right side of the gel are the Cd
products from the same three specimens. In addition, a control Cd prod-
uct, C , is shown from a Vd1 clone. (B) Graph of the quantitation of the
Betascope results for the synovial fluid lymphocytes freshly isolated (SF 09)
or after culture with B. burgdorferi (SF 1 Bb). Each Vd is displayed as a
percentage of the total Vd cpm.
Table 2. Changes in Absolute Numbers of Synovial T Cell 
Subsets with Borrelia Stimulation
Fresh (total absolute
No. 5 1.1 3 106)
1 Borrelia (total absolute
No. 5 2.3 3 106)
Subset Percent
Absolute No.
(3 105) Percent
Absolute No.
(3 105)
CD41 52.6 5.8 18.0 4.1
CD81 28.2 3.1 29.6 6.8
gd1 20.0 2.2 45.8 10.5
Synovial fluid lymphocytes from patient No. 2 were analyzed for sur-
face phenotype and absolute counts were determined when freshly iso-
lated and after seven days of stimulation with B. burgdorferi.
Figure 3. High level expres-
sion of surface Fas by synovial
CD41 cells. Mononuclear cells
from freshly isolated Lyme ar-
thritis synovial fluid or PBL were
immunofluorescently stained for
surface expression of Fas and ei-
ther CD4, CD8, or gd. Number
insets represent percent of posi-
tively stained cells. Only the
CD41 subset of synovial fluid
cells contains a large proportion
of Fashigh cells.
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trol staining for Fas-Fc was determined using a human IL4
receptor-Fc (IL4R-Fc) fusion protein (as surface-bound
IL4 would not be anticipated for a secreted cytokine). Fig.
4 A (column 3) illustrates results of staining using the Fas-
Fc fusion protein, on represetative ab (114B) and gd (2.11)
synovial T cell clones. By this method, surface FasL protein
was expressed on a considerably higher proportion of the
gd cells than on the B. burgdorferi–reactive ab T cell clones
seven days after the last stimulation. Similar findings were
seen with an additional two ab and two gd synovial T cell
clones. In contrast, the levels of surface Fas antigen on the
gd clones were somewhat less than on the ab clones, (Fig.
4 A, column 4).
The anti-FasL antibody confirmed the disparity in surface
FasL expression between synovial gd versus ab T cell clones.
Fig. 4 B (column 1) shows that 7 d after antigenic stimu-
lation of the Borrelia-reactive ab (114B) and gd (2.11)
clones, surface FasL was present on the gd clone, but was
only marginally detectable on the ab clone. This finding
was consistent for three ab and three gd clones studied.
However, the ab clones were capable of induction of FasL
upon stimulation, as shown after 3 h of activation with
PMA and ionomycin. In agreement with a recent report
(27), FasL expression on the T cell line, Molt 4, was en-
hanced by blocking metalloprotease activity with EDTA
(Fig. 4 B, column 4). This was less consistently observed
for the ab T cell clones, and was not observed for the gd
clones. It was particularly striking that the levels of FasL on
the gd clones remained detectable for at least 10 d follow-
ing stimulation with B. burgdorferi (Fig. 4 B, column 1).
This is in distinct contrast to ab T cells which express FasL
only transiently after activation (21; Roessner, K., unpub-
lished observations).
Synovial gd cells induce apoptosis of CD41 cells in a Fas-
dependent manner. To further explore whether the Lyme
arthritis synovial fluid gd T cell clones might be cytolytic
toward T lymphocytes expressing high levels of surface Fas,
the Jurkat T cell line was initially used as a representative
Fashigh target. Fig. 5 A shows that the gd clones manifested
very efficient cytolytic activity toward Jurkat cells, with
50% maximal lysis achieved at an effector/target ratio be-
tween 10:1 and 3:1. This finding was remarkably consistent
for each of five different Vd1 clones tested from two pa-
tients. In contrast, Borrelia-reactive CD41 ab T cell clones
manifested little, if any, cytolysis of Jurkat cells (data not
shown). Cytolysis by the gd clones was not inhibited by
antibodies to TCR-gd, HLA class I or II, but was blocked
by anti–LFA-1 antibody (Fig. 5 C), supporting the notion
that cytolysis was dependent on cell contact.
The potential contribution of Fas to cytolysis by gd cells
Figure 4. Lyme arthritis synovial gd clones express
high levels of FasL. (A) Surface FasL expression using a
Fas-Fc fusion protein (column 3) is shown for a B. burg-
dorferi–reactive ab T cell clone (114B) and a synovial gd
clone (2.11). Negative staining controls included either
second step fluorescein–anti-Fc antibody alone (column
1), or initial staining with IL4R-Fc followed by second
step anti-Fc antibody (column 2). Column 4 indicates the
levels of Fas expression by the same clones. (B) Surface
FasL expression detected by an anti–human FasL rabbit
antiserum (C-20) purified using a FasL-sepharose col-
umn. Cell lines included the T cell leukemic line, molt
4, and the ab and gd T cell clones used in A. Shown is
the control staining using rabbit immunoglobulin ( faint
line) superimposed on the staining with the anti-FasL an-
tibody (dark line). T cell clones were examined either
seven days after the last stimulation with B. burgdorferi
(unstimulated), or 3 h after activation with PMA and ion-
omycin (iono). Cells were also analyzed in the absence or
presence of the metalloprotease inhibitor EDTA in an ef-
fort to block degradation of surface FasL (27). Open
numbers in histograms represent the percent of positive
cells above background staining. Numbers in parentheses
indicate the mean fluorescence intensity of the positively
stained cells.
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was examined using three approaches. Initially, two Faslow
variants of Jurkat cells, H7 and B4, were independently de-
rived by radiation mutagenesis followed by selection with
lytic anti-Fas antibody, M2. H7 expresses 3% of the levels
of Fas found on wild-type Jurkat cells, whereas B4 displays 1%
(Fig. 5 B). Fig. 5 A demonstrates that the efficiency of cy-
tolysis of both Faslow variants was diminished approximately
two- to threefold compared to that observed with wild-
type Jurkat cells. However, lysis of the Jurkat Faslow variants
was not completely eliminated, suggesting that part of the
cytolytic activity of the gd clones was independent of Fas.
This was supported by anti-Fas antibody blocking studies.
Inhibition of Jurkat cell cytolysis by the gd clones was
also achieved using a nonlytic anti-Fas antibody, M38 (24).
Fig. 5 D shows that the blocking of cytolysis with M38
was partial, achieving 30–50% inhibition at the highest
concentration of antibody (10 mg/ml), whereas control
mouse Ig did not block cytolysis. In vitro cytolysis consists
of a calcium-independent component mediated by Fas and
a calcium-dependent component delivered by perforin
(18–20). Blocking perforin action by chelation of calcium
with EGTA also resulted in partial inhibition of Jurkat cy-
tolysis, which could then be blocked almost completely by
the further addition of anti-Fas antibody (Fig. 5 D). A third
method of disrupting Fas-FasL interaction used the Fas-Fc
fusion protein. Fig. 5 E shows that Fas-Fc, but not IL4R-
Fc, partially blocked cytolysis of Jurkat cells by the gd
clones, though to a slightly lesser extent than did nonlytic
anti-Fas antibody.
The above findings show that gd clones derived from
synovial fluid express prolonged and high levels of FasL and
suggest that gd cells preferentially lyse Fashigh cells. To di-
rectly assess whether uncloned synovial gd cells function in
a similar manner, FasL expression was determined on syn-
ovial lymphocytes after Borrelia stimulation. As shown in
Fig. 6 A, 7 d after activation, FasL expression was confined
exclusively to a major proportion of the gd cells. FasL was
still expressed by at least 50% of the synovial gd cells for as
long as 11 d after Borrelia stimulation.
To further assess the contribution of the gd cells to the
loss of synovial CD41 cells, the gd subset was depleted by
flow cytometric sorting and compared to a nondepleted
Figure 5. Lyme arthritis synovial fluid Vd1 T cell clones
are highly lytic in a Fas-dependent manner. Effector Vd1
clones were combined at the ratios indicated with 51Cr-
labeled Jurkat target T cells in a four h cytolytic assay. (A)
Comparison of cytolytic activity toward wild-type Fashigh
Jurkat T cells (closed squares) compared with two Faslow Jur-
kat variants, H7 (open squares) and B4 (open circles), which
express, respectively, 3 and 1% of surface Fas levels ob-
served on wild-type Jurkat cells. (B) Level of Fas expres-
sion on wild-type Jurkat T cells and two variants, H7 and
B4, selected by repeated irradiation and culture in the pres-
ence of lytic anti-Fas antibody, M2. Number insets indi-
cate the mean fluorescence intensity of the gated area. (C)
Attempts to block gd cytolytic activity using antibodies to
HLA class I (closed squares), HLA class II (open squares),
TCR-gd (open circles), and anti–LFA-1 (closed triangles). The
anti–LFA-1 study was part of a separate experiment in
which the baseline cytolysis was 42%. (D) Ability of vari-
ous concentrations of nonlytic anti-Fas antibody M38 to
inhibit cytolysis of wild-type Jurkat cells by the Vd1
clones. Cytolysis assay was also performed in the absence
(closed squares) or presence (open squares) of 2.5 mM EGTA, an inhibitor of calcium-dependent perforin activity (18). Lysis in the presence of control IgG
antibody (10 mg/ml) is shown by the closed triangle. (E) Inhibition of Jurkat cytolysis by the Vd1 clones 16 and 2.11 in the presence of 10 mg/ml of ei-
ther anti-Fas antibody M38, Fas-Fc fusion protein, both, or IL4R-Fc fusion protein.
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sample of the same specimen after five days of stimulation
with B. burgdorferi. During this period, the gd cells in the
nondepleted synovial sample expanded from 4.3% to 11%
(Fig. 6 B). This was accompanied by a decreased propor-
tion of CD41 cells, from 35.6 to 25.3%. In striking con-
trast, the gd-depleted population contained only 4% gd
cells after 5 d and manifested a predominance of CD41
cells (40.8%)(Fig. 6 B). In addition, the CD41 cells in the
4-day cultures contained a subpopulation of CD4low cells
which comprised a greater proportion of the total CD41
cells in the gd-replete than the gd-depleted specimen (Fig.
6 B, arrow inset). These CD4low cells represented apoptotic
cells, as determined by the TUNEL assay combined with
surface staining and analyzed by flow cytometry (Fig. 6 C).
Smaller proportions of apoptotic cells were also observed in
the CD81 and gd1 subsets. Observations similar to these
have been made with gd depletion of two additional Lyme
synovial fluid specimens, as well as by noting a depletion of
CD41 cells when Vd1 cloned T cells were added to cul-
tures of PBL that have been stimulated with B. burgdorferi
(data not shown).
To assess whether the appearance of the apoptotic CD4low
subset in the gd-replete cultures was in part Fas-mediated,
FasL was blocked using the Fas-Fc fusion protein. Synovial
fluid lymphocytes were stimulated with B. burgdorferi in the
presence of either no additives, Fas-Fc, or control mouse
IgG. As shown in Fig. 7, the appearance of apoptotic
CD4low cells occurred beginning about five days after Borre-
lia stimulation. The proportion of this subset increased dra-
matically thereafter in all cultures except that containing
Fas-Fc. The findings support the view that the gd subset
induces apoptosis of synovial CD41 cells at least partly
through Fas/FasL interactions.
Figure 6. Synovial gd cells express FasL and their presence correlates
with apoptosis of synovial CD41 cells. (A) Lyme arthritis synovial fluid
lymphocytes were stimulated with B. burgdorferi for 5 d and then stained
with anti-gd and monoclonal anti-FasL, A11. (B) Depletion of gd cells
from fresh Lyme arthritis synovial fluid was performed by flow cytometric
sorting. Sorted and unsorted synovial fluid lymphocytes from the same
specimen were then cultured with B. burgdorferi for 4 d and stained for ex-
pression of TCR-gd, CD4, and CD8. Note the subpopulation of CD4low
cells indicated by the white arrow insets, and the percent in that group
noted by the number over the arrow. The CD4low cells comprise a larger
proportion of the total CD41 subset in the cultures containing gd cells
(gd–nondepleted), even though they contained overall a smaller propor-
tion of CD41 cells compared to the gd-depleted cultures. These findings
were consistent in three experiments. (C) Determination of DNA frag-
mentation in a second gd-nondepleted synovial culture using the TUNEL
assay combined with surface labeling and flow cytometry. Note that the
CD4low subpopulation is the subset undergoing apoptosis.
Figure 7. FasL inhibition prevents appearance of CD4low apoptotic sub-
set. Lyme arthritis synovial fluid mononuclear cells were stimulated with
B. burgdorferi (B.b.) in the presence of no additives (closed circles), or 10 mg/ml
of either Fas-Fc (closed squares), or murine IgG (open circles). After the indi-
cated day of stimulation, cultures were analyzed for expression of CD4,
CD8, and gd. Shown is the expression of apoptotic CD4low cells (as iden-
tified by TUNEL in Fig. 6 C) as a percentage of the total CD41 cells.
The results are representative of two experiments.
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Discussion
The collective observations suggest an immunoregula-
tory circuit whereby synovial Vd1 T cells bearing high lev-
els of FasL selectively restrict the expansion of infiltrating
inflammatory Fashigh CD41 lymphocytes through cytolysis
in a Fas-dependent manner. The findings are in agreement
with recent studies showing that FasL mRNA expression
by T cells is highest in the gd subset (21). Not only were
levels of surface FasL high on the Vd1 clones, they re-
mained elevated for considerably longer periods than simi-
larly activated ab T cells. This may serve to explain the
broad spectrum of cytolytic activity that has frequently
been observed for many gd cells (2, 16). The results parallel
other recent descriptions of immunosuppression resulting
from constitutive expression of FasL by Sertoli cells in the
testis (22), and by components of the eye (23).
The current findings may also bear on observations that
collagen-induced arthritis in mice (34) and adjuvant arthri-
tis in rats (35) are both more severe following administra-
tion of anti-gd antibody. Collagen-induced arthritis is also
more aggressive in mice bearing a genetic deletion of the d
locus (Lefrancois, L., personal communication). Similar re-
sults have been observed in a model of orchitis in which gd
depletion accelerated the inflammatory response (36). gd T
cells have also been observed to modulate the functional
profile of CD41 cells. In certain instances this has mani-
fested as selectively inhibiting TH2-dependent cytokine re-
sponses, such as IgE production in an allergy model (37)
and Coxsackievirus-induced myocarditis (38). The result-
ing TH1 bias may be due solely to the production of the
TH1-type cytokine, IFNg, by gd cells (37), but may also
reflect a greater sensitivity of TH2 cells to Fas-mediated apop-
tosis. In this regard, it is noteworthy that B. burgdorferi–
reactive CD41 T cells from Lyme arthritis patients express
a TH1 cytokine phenotype (39). Studies are in progress to
determine whether a TH1 enrichment results in the residual
CD41 synovial T cells following stimulation with B. burg-
dorferi.
Lyme arthritis synovial gd T cells also represent a rare in-
stance where gd T cell clones obtained from a human in-
fectious disease manifest a proliferative response in the pres-
ence of the causative agent. This does not establish that
Lyme arthritis synovial gd cells are responding directly to a
Borrelial component. It is entirely possible that B. burgdor-
feri induces the appearance of surface molecules to which
Vd1 cells respond secondarily. Cutaneous lesions in leprosy
also contain gd T cells that react to the causative agent,
Mycobacterium leprae (9). The repertoire of gd cells that react
to mycobacterial products is restricted in both humans and
mice (11, 40), and in some instances involves recognition
of nonpeptide components such as prenyl pyrophosphates
(15, 41). Conceivably, gd cells in Lyme arthritis may also
recognize nonprotein components of B. burgdorferi. On bal-
ance, the current findings are consistent with the concept
that gd cells participate in the defense against infectious
agents while modulating the immune response through
Fas-mediated apoptosis.
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